• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于前列腺光动力治疗光通量率的快速非均匀算法。

A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy.

作者信息

Chang Chang, Wang Ken K-H, Zhu Timothy C

机构信息

Department of Radiation Oncology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

出版信息

Proc SPIE Int Soc Opt Eng. 2010 Mar 2;7551. doi: 10.1117/12.843000.

DOI:10.1117/12.843000
PMID:26005241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4438753/
Abstract

To accurately calculate light fluence rate distribution in prostate photodynamic therapy (PDT), optical heterogeneity has to be taken into account. Previous study has shown that a kernel based on analytic solution of the diffusion equation can perform the calculation with accuracy comparable to Finite-element method. An assumption is made that light fluence rate detected at a point in the medium is affected primarily by the optical properties of points (or elements) on the line between the source and the point. The exponential decay term of the light fluence rate is expressed as an integral of effective attenuation coefficient of each point along the line. The kernel method is first developed for a point source and then extended for a linear source. A linear source is considered being composed of multiple point sources and light fluence rate is summation of the fluence rates generated by the point sources. In this study, we have implemented a fast ray-trace algorithm to substantially speed up the calculation. The kernel calculation is compared with FEM calculation and is examined with light fluence rate measurements. The examination with clinical measurement data shows that calculated fluence rates present similar features in distribution as the measurement, with errors of 30%-70% for the peak fluence rates. We concluded that our heterogeneous algorithm is potentially valuable for light fluence rate optimization during interstitial PDT.

摘要

为了准确计算前列腺光动力疗法(PDT)中的光通量率分布,必须考虑光学不均匀性。先前的研究表明,基于扩散方程解析解的核可以实现与有限元方法相当的精度计算。假设在介质中某一点检测到的光通量率主要受源点与该点之间连线上各点(或单元)光学特性的影响。光通量率的指数衰减项表示为沿该线各点有效衰减系数的积分。核方法首先针对点光源开发,然后扩展到线光源。线光源被视为由多个点光源组成,光通量率是这些点光源产生的通量率之和。在本研究中,我们实现了一种快速光线追踪算法,以大幅加快计算速度。将核计算与有限元计算进行比较,并通过光通量率测量进行检验。临床测量数据检验表明,计算得到的通量率分布特征与测量结果相似,峰值通量率误差为30%-70%。我们得出结论,我们的非均匀算法在间质光动力疗法中对光通量率优化具有潜在价值。

相似文献

1
A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy.一种用于前列腺光动力治疗光通量率的快速非均匀算法。
Proc SPIE Int Soc Opt Eng. 2010 Mar 2;7551. doi: 10.1117/12.843000.
2
Modeling light fluence rate distribution in optically heterogeneous prostate photodynamic therapy using a kernel method.使用核方法对光学异质性前列腺光动力治疗中的光通量率分布进行建模。
Proc SPIE Int Soc Opt Eng. 2007 Jan 20;6427. doi: 10.1117/12.702798.
3
Integrated light dosimetry system for prostate photodynamic therapy.用于前列腺光动力治疗的集成光剂量测定系统。
Proc SPIE Int Soc Opt Eng. 2008 Jan 19;6845. doi: 10.1117/12.763806.
4
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.异质性前列腺光动力治疗中光源参数的优化
Phys Med Biol. 2008 Aug 7;53(15):4107-21. doi: 10.1088/0031-9155/53/15/007. Epub 2008 Jul 8.
5
A heterogeneous algorithm for PDT dose optimization for prostate.一种用于前列腺光动力疗法(PDT)剂量优化的异构算法。
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640B. doi: 10.1117/12.809897.
6
Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.光动力疗法中异质性前列腺体内光通量分布的测定
Phys Med Biol. 2008 Apr 21;53(8):2103-14. doi: 10.1088/0031-9155/53/8/007. Epub 2008 Mar 27.
7
Study of light fluence rate distribution in photodynamic therapy using finite-element method.基于有限元法的光动力疗法中光通量率分布研究
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.646251.
8
A Treatment Planning System for Pleural PDT.一种用于胸膜光动力疗法的治疗计划系统。
Proc SPIE Int Soc Opt Eng. 2010 Mar 2;7551. doi: 10.1117/12.843044.
9
A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.一种用于间质光动力疗法中反应性单线态氧的异构优化算法。
Proc SPIE Int Soc Opt Eng. 2010 Jan;7551. doi: 10.1117/12.842968.
10
light dosimetry of interstitial PDT of human prostate.人类前列腺间质光动力疗法的光剂量测定
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.646220.

引用本文的文献

1
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.肿瘤光动力疗法:基本原理、当前临床现状及未来方向
Cancers (Basel). 2017 Feb 18;9(2):19. doi: 10.3390/cancers9020019.
2
A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.一种用于间质光动力疗法中反应性单线态氧的异构优化算法。
Proc SPIE Int Soc Opt Eng. 2010 Jan;7551. doi: 10.1117/12.842968.

本文引用的文献

1
The role of photodynamic therapy (PDT) physics.光动力疗法(PDT)物理学的作用。
Med Phys. 2008 Jul;35(7):3127-36. doi: 10.1118/1.2937440.
2
Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.光动力疗法中异质性前列腺体内光通量分布的测定
Phys Med Biol. 2008 Apr 21;53(8):2103-14. doi: 10.1088/0031-9155/53/8/007. Epub 2008 Mar 27.
3
Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer.间质莫替沙芬镥介导的光动力疗法治疗前列腺癌的初步结果。
Lasers Surg Med. 2006 Jun;38(5):427-34. doi: 10.1002/lsm.20341.
4
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.镥莫替沙芬介导的间质光动力疗法用于局部复发性前列腺癌患者的I期试验的更新结果。
J Environ Pathol Toxicol Oncol. 2006;25(1-2):373-87. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.230.
5
Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.在莫替沙芬镥介导的光动力疗法期间对人体前列腺体内的光分布、光学特性、药物浓度和组织氧合进行测定。
J Photochem Photobiol B. 2005 Jun 1;79(3):231-41. doi: 10.1016/j.jphotobiol.2004.09.013. Epub 2004 Dec 2.
6
Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.在介导光动力疗法中测量的人体前列腺在732纳米处的光学特性。
Photochem Photobiol. 2005 Jan-Feb;81(1):96-105. doi: 10.1562/2004-06-25-RA-216.
7
In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.使用莫特沙芬镥介导的光动力疗法对正常犬前列腺在732纳米处的体内光学特性研究。
Photochem Photobiol. 2003 Jan;77(1):81-8. doi: 10.1562/0031-8655(2003)077<0081:ivopon>2.0.co;2.
8
Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.放疗后前列腺癌复发的光动力疗法:一项I期研究。
J Urol. 2002 Oct;168(4 Pt 1):1427-32. doi: 10.1016/S0022-5347(05)64466-7.
9
Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues.用于浑浊生物组织中光化学反应和荧光的点、线和面光源的光分布。
Photochem Photobiol. 1998 Jan;67(1):23-32.
10
Interstitial photodynamic therapy in the canine prostate.犬前列腺间质光动力疗法
Br J Urol. 1997 Dec;80(6):898-902. doi: 10.1046/j.1464-410x.1997.00460.x.